Inflammation is the physiological and
pathological response to cell injury, which results in the recruitment of
leukocytes and plasma proteins to affected tissue and activation of
tissue-resident macrophages causing para-inflammation. If the process becomes
unregulated, the inflammatory response that normally destroys and eliminates
pathogens is also capable of injuring normal tissues. First line management of
an unregulated inflammatory response is to limit excessive inflammation.
Traumeel is a
compound that is utilized by a wide variety of healthcare practitioners to
treat inflammatory states. It is composed of various
natural plant and mineral extracts, which target the inflammatory pathways following
soft-tissue injury. It is utilized extensively in Germany for multiple inflammatory
conditions.
Non-Steroidal
Anti-Inflammatory Drugs (NSAIDs) are a drug class that reduce pain, decrease
fever, prevent blood clots and, in higher doses, decrease inflammation. Although
highly effective, these medications have side effects
that limit both their short and long term use in many patients. However, Traumeel
does not have the severe side effect profile of NSAIDs and corticosteroids.
The purpose of this
document was to review and critique publications written about Traumeel and
Traumeel S, a proprietary formulation. Furthermore, this review would determine
if the literature supported substituting Traumeel for NSAIDs and
corticosteroids or if adding Traumeel to NSAID and corticosteroid treatment
protocols benefited patients with inflammation.
Many of the articles reviewed demonstrate that Traumeel can decrease
the incidence or severity of certain disease states that are associated with
inflammation. And Traumeel has been shown to be of benefit
in the treatment of certain musculoskeletal injuries when compared to
glucocorticoids and NSAIDs.
In conclusion, the literature
supports Traumeel as an effective alternative to NSAIDS and corticosteroids in
preventing stomatitis for patients undergoing chemotherapy. Traumeel also
provides pain-free outcomes following musculoskeletal and tissue injuries. However, further investigations of Traumeel are warranted to
identify mechanism of action, best route of administration, and most effective
treatment regimen.
Article by Dennis
Grech, et al, from USA.
Full access: http://mrw.so/5aiTRH
Image by Felipe Contreras Fernandez, from
Flickr-cc.
评论
发表评论